Peri-operative Foot CT Perfusion in CLI Patients
- Conditions
- Critical Limb Ischemia
- Registration Number
- NCT05575778
- Lead Sponsor
- Fudan University
- Brief Summary
To investigate the clinical value of quantitative analysis of peri-operative foot supply through CT perfusion in patients with critical limb ischemia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 90
- 18 to 80 years old;
- CLI patients with Fontaine grade III-IV or Rutherford grade 4-6 and underwent a successful revascularization;
- Patients completed both pre- and post-operative CTP workups;
- Patients signed the informed consent form and be able to complete the clinical follow-up for 12 months.
- Patients has participated in other clinical studies;
- Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate<60 ml/min)
- Any allergic constitution;
- Pregnancy and childbirth;
- Life expectancy<12 months.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pre-operative computed tomographic perfusion parameters 18months Pre-operative computed tomographic perfusion parameters, including peak intensity, time to peak, and etc, which would be obtained three days before revascularization.
Post-operative computed tomographic perfusion parameters 18months Post-operative computed tomographic perfusion parameters, including peak intensity, time to peak, and etc, which would be obtained three days ater revascularization.
Alteration of computed tomographic perfusion parameters 18months Alteration between post- (three days ater revascularization) and pre-operative (three days before revascularization) computed tomographic perfusion parameters
- Secondary Outcome Measures
Name Time Method Major adverse limb events 12months Major adverse limb events included major amputation or acute limb ishchemia for vasular causes.
Major adverse cardiovascular events 12months Major adverse cardiovascular events included myocardial infarction, ischemic stroke, or death from cadiovascular causes.
Trial Locations
- Locations (1)
Hua Dong Hospital Affiliated to Fu Dan University
🇨🇳Shanghai, China